Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Onderzoek naar oud antihypertensivum in de strijd tegen vanishing white matter
aug 2020